June 16, 2025

Updated Guidance on Antirheumatic Drug Use

New 2024 EULAR recommendations offer evidence-based guidance for the use of antirheumatic drugs during pregnancy, lactation, and conception planning in patients with rheumatic and musculoskeletal diseases.

Conexiant

June 11, 2025

8-Week Oral Therapy Approved for Acute HCV

The FDA has approved Mavyret for the treatment of acute hepatitis C, offering physicians a pangenotypic, 8-week oral regimen for early intervention.

Conexiant

June 11, 2025

Does COVID Vaccination Raise Miscarriage Risk?

COVID-19 vaccination during early pregnancy not associated with spontaneous abortion.

Conexiant

June 11, 2025

Spectroscopy Research Roundup: Handheld insights from Palace to Pregnancy

Miniaturized instruments, cervical insights, and the spectral layers of Qing Dynasty art

The Analytical Scientist

June 09, 2025

New Fixed-Dose RSV Antibody Approved

The FDA has approved enflonsia, a fixed-dose monoclonal antibody, for preventing RSV lower respiratory tract disease in infants during their first season.

Conexiant

June 06, 2025

Could Spices Be Irritating the Vulva?

Patch testing revealed clinically relevant allergies to metals, spices, fragrances, and preservatives.

Conexiant

June 05, 2025

Sister’s History Tied to 10-Fold Increase in Postpartum Psychosis Risk

A population-based study discussed at APAAM25 links full sibling history to increased risk of postpartum psychosis – but notes the absolute risk remains low.

Conexiant

June 02, 2025

New COVID Vaccine Approved for High-Risk Groups

After showing higher efficacy and a comparable safety profile to Spikevax, the FDA has approved Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk patients.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant